NFKB1 and Alzheimer disease: The present study shows that RCW relieves AD symptoms in an in vitro model (TNF-α/IFN-γ-stimulated HaCaT cells) by exerting antioxidant effects; suppressing inflammatory mediators; and increasing the levels of proteins that form the skin, via regulating the NF-κB signaling pathway.